Statins inhibit matrix metalloproteinase release from human lung fibroblasts

Kamio K, Liu X. D, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard S. I.

Source: Eur Respir J 2010; 35: 637-646
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kamio K, Liu X. D, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard S. I.. Statins inhibit matrix metalloproteinase release from human lung fibroblasts. Eur Respir J 2010; 35: 637-646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biological role of matrix metalloproteinases: a critical balance
Source: Eur Respir J 2011; 37: 191-208
Year: 2011



Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008

Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Effects of steroids and b-mimetics on matrix metalloproteinases expression in human lung primary cells
Source: Eur Respir J 2003; 22: Suppl. 45, 453s
Year: 2003

Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008


Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils
Source: Eur Respir J 2009; 34: 1167-1170
Year: 2009



Promotional effect of 27-hydroxycholesterol in the release of matrix metalloproteinases by lung fibroblasts
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013

Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002

Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002



Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004

Statins inhibit human lung fibroblast production and activation of MMPs
Source: Eur Respir J 2007; 30: Suppl. 51, 692s
Year: 2007

Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
Source: Eur Respir J 2001; 18: 838-845
Year: 2001



Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009


A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Source: Eur Respir J 2011; 38: 1200-1214
Year: 2011



Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012



Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro
Source: Eur Respir J 2004; 23: 671-678
Year: 2004



Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005



Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008